Compare MDT & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDT | ABT |
|---|---|---|
| Founded | 1949 | 1888 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.9B | 152.9B |
| IPO Year | 2014 | 2006 |
| Metric | MDT | ABT |
|---|---|---|
| Price | $81.32 | $91.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 20 |
| Target Price | $108.21 | ★ $130.90 |
| AVG Volume (30 Days) | ★ 10.3M | 9.5M |
| Earning Date | 06-03-2026 | 04-16-2026 |
| Dividend Yield | ★ 3.58% | 2.76% |
| EPS Growth | ★ 30.80 | N/A |
| EPS | ★ 2.76 | 0.61 |
| Revenue | $33,537,000,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $8.91 | $10.75 |
| Revenue Next Year | $6.54 | $8.10 |
| P/E Ratio | ★ $29.72 | $148.57 |
| Revenue Growth | 3.62 | ★ 5.67 |
| 52 Week Low | $73.31 | $81.97 |
| 52 Week High | $106.33 | $137.49 |
| Indicator | MDT | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 57.22 |
| Support Level | $74.40 | $84.96 |
| Resistance Level | $89.01 | $112.81 |
| Average True Range (ATR) | 1.61 | 1.84 |
| MACD | 0.83 | 0.99 |
| Stochastic Oscillator | 84.03 | 81.51 |
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.